Cargando…

Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer

PURPOSE: We investigated the correlation of (18)F-AlF-NOTAPRGD2 ((18)F-RGD) uptake during positron emission tomography (PET) with tumoral programmed death-ligand 1 (PD-L1) expression and explored its potential in immune checkpoint inhibitor treatment. METHODS: Forty-two mice were subcutaneously inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Leilei, Liu, Jingru, Wang, Shasha, Bai, Menglin, Wu, Min, Gao, Zhenhua, Li, Jianing, Yu, Jinming, Liu, Jie, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279559/
https://www.ncbi.nlm.nih.gov/pubmed/35846323
http://dx.doi.org/10.3389/fendo.2022.913631
_version_ 1784746423750754304
author Wu, Leilei
Liu, Jingru
Wang, Shasha
Bai, Menglin
Wu, Min
Gao, Zhenhua
Li, Jianing
Yu, Jinming
Liu, Jie
Meng, Xue
author_facet Wu, Leilei
Liu, Jingru
Wang, Shasha
Bai, Menglin
Wu, Min
Gao, Zhenhua
Li, Jianing
Yu, Jinming
Liu, Jie
Meng, Xue
author_sort Wu, Leilei
collection PubMed
description PURPOSE: We investigated the correlation of (18)F-AlF-NOTAPRGD2 ((18)F-RGD) uptake during positron emission tomography (PET) with tumoral programmed death-ligand 1 (PD-L1) expression and explored its potential in immune checkpoint inhibitor treatment. METHODS: Forty-two mice were subcutaneously injected with CMT-167 lung carcinoma cells. A total of 30 mice with good growth tumor and good general condition were selected. (18)F-RGD PET scanning was performed on days 0, 2, 4, 6, 9, and 11 with five mice per day. Immunohistochemistry (IHC) for PD-L1 was performed on each specimen obtained from tumors. Thirty patients with advanced non-small cell lung cancer (NSCLC) were scanned using (18)F-RGD PET/CT, and Milliplex multifactor detection analyzed serum PD-1/PD-L1 expression of twenty-eight of them. Thirteen of them were analyzed immunohistochemically using core needle biopsy samples obtained from primary tumors. RESULTS: Thirty mice were scanned by (18)F-RGD PET/CT and analyzed for PD-L1 expression in tumor cells by IHC finally. Maximum standard uptake value (SUVmax) and mean SUV (SUVmean) were significantly lower in relatively-higher-PD-L1-expression tumors than in relatively-low-PD-L1-expression tumors (P < 0.05). In patients, the SUVmax was significantly negatively correlated with tumoral PD-L1 expression by IHC (P=0.014). SUVmean, peak SUV (SUVpeak), and gross tumor volume (GTV) were also negatively correlated with PD-L1, but without significance (P > 0.05). SUVmax, SUVmean, SUVpeak, and GTV were negatively correlated with serum PD-1 and PD-L1, but not significantly. According to the receiver operating characteristic curve analysis, significant correlations between SUVmax and tumoral PD-L1 expression in both mice and patients were present (P < 0.05). CONCLUSION: Higher (18)F-RGD uptake is correlated with depressed PD-L1 expression in tumor cells, and SUVmax is the best parameter to display tumoral expression of PD-L1. (18)F-RGD PET may be useful for reflecting the immune status of NSCLC.
format Online
Article
Text
id pubmed-9279559
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92795592022-07-15 Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer Wu, Leilei Liu, Jingru Wang, Shasha Bai, Menglin Wu, Min Gao, Zhenhua Li, Jianing Yu, Jinming Liu, Jie Meng, Xue Front Endocrinol (Lausanne) Endocrinology PURPOSE: We investigated the correlation of (18)F-AlF-NOTAPRGD2 ((18)F-RGD) uptake during positron emission tomography (PET) with tumoral programmed death-ligand 1 (PD-L1) expression and explored its potential in immune checkpoint inhibitor treatment. METHODS: Forty-two mice were subcutaneously injected with CMT-167 lung carcinoma cells. A total of 30 mice with good growth tumor and good general condition were selected. (18)F-RGD PET scanning was performed on days 0, 2, 4, 6, 9, and 11 with five mice per day. Immunohistochemistry (IHC) for PD-L1 was performed on each specimen obtained from tumors. Thirty patients with advanced non-small cell lung cancer (NSCLC) were scanned using (18)F-RGD PET/CT, and Milliplex multifactor detection analyzed serum PD-1/PD-L1 expression of twenty-eight of them. Thirteen of them were analyzed immunohistochemically using core needle biopsy samples obtained from primary tumors. RESULTS: Thirty mice were scanned by (18)F-RGD PET/CT and analyzed for PD-L1 expression in tumor cells by IHC finally. Maximum standard uptake value (SUVmax) and mean SUV (SUVmean) were significantly lower in relatively-higher-PD-L1-expression tumors than in relatively-low-PD-L1-expression tumors (P < 0.05). In patients, the SUVmax was significantly negatively correlated with tumoral PD-L1 expression by IHC (P=0.014). SUVmean, peak SUV (SUVpeak), and gross tumor volume (GTV) were also negatively correlated with PD-L1, but without significance (P > 0.05). SUVmax, SUVmean, SUVpeak, and GTV were negatively correlated with serum PD-1 and PD-L1, but not significantly. According to the receiver operating characteristic curve analysis, significant correlations between SUVmax and tumoral PD-L1 expression in both mice and patients were present (P < 0.05). CONCLUSION: Higher (18)F-RGD uptake is correlated with depressed PD-L1 expression in tumor cells, and SUVmax is the best parameter to display tumoral expression of PD-L1. (18)F-RGD PET may be useful for reflecting the immune status of NSCLC. Frontiers Media S.A. 2022-06-30 /pmc/articles/PMC9279559/ /pubmed/35846323 http://dx.doi.org/10.3389/fendo.2022.913631 Text en Copyright © 2022 Wu, Liu, Wang, Bai, Wu, Gao, Li, Yu, Liu and Meng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wu, Leilei
Liu, Jingru
Wang, Shasha
Bai, Menglin
Wu, Min
Gao, Zhenhua
Li, Jianing
Yu, Jinming
Liu, Jie
Meng, Xue
Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
title Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
title_full Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
title_fullStr Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
title_full_unstemmed Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
title_short Negative Correlation Between (18)F-RGD Uptake via PET and Tumoral PD-L1 Expression in Non-Small Cell Lung Cancer
title_sort negative correlation between (18)f-rgd uptake via pet and tumoral pd-l1 expression in non-small cell lung cancer
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279559/
https://www.ncbi.nlm.nih.gov/pubmed/35846323
http://dx.doi.org/10.3389/fendo.2022.913631
work_keys_str_mv AT wuleilei negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT liujingru negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT wangshasha negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT baimenglin negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT wumin negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT gaozhenhua negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT lijianing negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT yujinming negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT liujie negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer
AT mengxue negativecorrelationbetween18frgduptakeviapetandtumoralpdl1expressioninnonsmallcelllungcancer